Legal Representation
Attorney
Jennifer Lee Taylor
USPTO Deadlines
Application History
15 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Jul 18, 2022 | MAB2 | E | ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND | Loading... |
| Jul 17, 2022 | ABN2 | O | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE | Loading... |
| Jan 2, 2022 | GNFN | O | NOTIFICATION OF FINAL REFUSAL EMAILED | Loading... |
| Jan 2, 2022 | GNFR | O | FINAL REFUSAL E-MAILED | Loading... |
| Jan 2, 2022 | CNFR | R | FINAL REFUSAL WRITTEN | Loading... |
| Dec 13, 2021 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Dec 13, 2021 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Dec 13, 2021 | ALIE | A | ASSIGNED TO LIE | Loading... |
| Dec 8, 2021 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Jun 8, 2021 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Jun 8, 2021 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Jun 8, 2021 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| May 28, 2021 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Feb 16, 2021 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Dec 12, 2020 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 001
(Based on Intent to Use) Reagents and antigens for research purposes
Class 005
(Based on Use in Commerce) Pharmaceutical preparation for the treatment of viral and infectious diseases; vaccines for the prevention of viral and infectious diseases; diagnostic kits comprised of medical diagnostic reagents and assays for testing of bodily fluids for use in disease detection, namely, cardiovascular diseases, central and peripheral nervous system diseases, respiratory diseases, gastroenterological diseases, intestinal diseases, liver diseases, lung diseases, pancreatic diseases, endocrine diseases, cancer, tumors, allergies, rheumatic diseases, inflammatory diseases, autoimmune diseases, blood diseases, gynecological diseases, urological diseases, genital diseases, sexually-transmitted diseases, ophthalmological diseases, dermatological diseases, infectious diseases, internal medicine diseases, metabolic diseases, diabetes, neuromuscular diseases, neurodegenerative diseases, and age-related diseases; medical diagnostic reagents; antigens for medical purposes
First Use Anywhere:
Oct 8, 2020
First Use in Commerce:
Oct 12, 2020
Class 010
(Based on Use in Commerce) Diagnostic kits consisting primarily of probes, buffers, and reagents for use in microbial and disease testing
First Use Anywhere:
Feb 7, 2020
First Use in Commerce:
Mar 26, 2020
Class 044
(Based on Use in Commerce) Healthcare information services; medical diagnostic testing services; providing medical diagnostic testing services via kiosks
First Use Anywhere:
Feb 7, 2020
First Use in Commerce:
Mar 26, 2020
Classification
International Classes
001
005
010
044